High-dose intravenous immunoglobulin G improves systemic inflammation in a rat model of CLP-induced sepsis

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Intensive Care Medicine

• Publication date

  2008-05-24

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00134-008-1161-1PMID 18500418
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• IMMUNOGLOBULIN M-ENRICHED HUMAN INTRAVENOUS IMMUNOGLOBULINS REDUCE LEUKOCYTE-ENDOTHELIAL CELL INTERACTIONS AND ATTENUATE MICROVASCULAR PERFUSION FAILURE IN NORMOTENSIVE ENDOTOXEMIA

  2007cited by this paper
• Circulating high-mobility group box 1 (HMGB1) concentrations are elevated in both uncomplicated pneumonia and pneumonia with severe sepsis*

  2007cited by this paper
• Meta-analysis: Intravenous Immunoglobulin in Critically Ill Adult Patients with Sepsis

  2007cited by this paper
• Systemic and local high mobility group box 1 concentrations during severe infection

  2007cited by this paper
• Score‐based immunoglobulin G therapy of patients with sepsis: The SBITS study *

  2007cited by this paper
• Recognizing and Managing Severe Sepsis: A Common and Deadly Threat

  2007cited by this paper
• Polyclonal intravenous immunoglobulin for the treatment of severe sepsis and septic shock in critically ill adults: A systematic review and meta‐analysis *

  2007cited by this paper
• A Human Monoclonal Immunoglobulin M Reduces Bacteremia and Inflammation in a Mouse Model of Systemic Pneumococcal Infection

  2007cited by this paper
• NF-κB activation as a pathological mechanism of septic shock and inflammation

  2006cited by this paper
• Year in review in intensive care medicine, 2005. II. Infection and sepsis, ventilator-associated pneumonia, ethics, haematology and haemostasis, ICU organisation and scoring, brain injury

  2006cited by this paper
• High mobility group box 1 protein interacts with multiple Toll-like receptors.

  2006cited by this paper
• HMGB1 SIGNALS THROUGH TOLL-LIKE RECEPTOR (TLR) 4 AND TLR2

  2006cited by this paper
• NF-kappa B activation as a pathological mechanism of septic shock and inflammation.

  2006cited by this paper
• The role of high mobility group box-1 protein in severe sepsis

  2006cited by this paper
• EFFECTS OF HIGH-DOSE OF INTRAVENOUS IMMUNOGLOBULIN AND ANTIBIOTICS ON SURVIVAL FOR SEVERE SEPSIS UNDERGOING SURGERY

  2005cited by this paper
• Plasma concentrations and importance of high mobility group box protein in the prognosis of organ failure in patients with disseminated intravascular coagulation

  2005cited by this paper
• Release of High Mobility Group Box 1 by Dendritic Cells Controls T Cell Activation via the Receptor for Advanced Glycation End Products1

  2005cited by this paper
• Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock*

  2005cited by this paper
• Year in review in intensive care medicine, 2004. I. Respiratory failure, infection, and sepsis

  2004cited by this paper
• Contributions of high mobility group box protein in experimental and clinical acute lung injury.

  2004cited by this paper
• Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells.

  2003cited by this paper
• Reversing established sepsis with antagonists of endogenous high-mobility group box 1

  2003cited by this paper
• Activation of gene expression in human neutrophils by high mobility group box 1 protein.

  2003cited by this paper
• Heparin Nebulization Attenuates Acute Lung Injury in Sepsis Following Smoke Inhalation in Sheep

  2002cited by this paper
• HMG‐1 REDISCOVERED AS A CYTOKINE

  2001cited by this paper
• Predictive Value of Nuclear Factor κB Activity and Plasma Cytokine Levels in Patients with Sepsis

  2000cited by this paper
• Activation of NF-kappaB varies in different regions of the gastrointestinal tract during endotoxemia.

  2000cited by this paper
• Unresponsiveness of MyD88-deficient mice to endotoxin.

  1999cited by this paper
• HMG-1 as a late mediator of endotoxin lethality in mice.

  1999cited by this paper
• Regulation of DNA-Dependent Activities by the Functional Motifs of the High-Mobility-Group Chromosomal Proteins

  1999cited by this paper
• Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes.

  1999cited by this paper
• Supplemental Immune Globulins in Sepsis

  1999cited by this paper
• Acute Lung Injury

  1998cited by this paper
• Transcription factors as activators of gene transcription: AP-1 and NF-kappa B.

  1997cited by this paper
• Role of NFkappaB in the mortality of sepsis.

  1997cited by this paper
• Transcription factors as activators of gene transcription: AP-1 and NF-kappa B.

  1997cited by this paper
• Therapeutic application of intravenous human natural immunoglobulin preparation.

  1996cited by this paper
• Nuclear factor-kappa B is activated in alveolar macrophages from patients with acute respiratory distress syndrome.

  1996cited by this paper
• High-mobility group protein HMG-I localizes to G/Q- and C-bands of human and mouse chromosomes

  1989cited by this paper

• HMGB1–Platelet Interactions: Mechanisms and Targeted Therapy Strategies

  2025cites this paper
• Destabilisation of T cell-dependent humoral immunity in sepsis

  2024cites this paper
• Clinical practice of sepsis-induced immunosuppression: Current immunotherapy and future options

  2023cites this paper
• LCZ696 attenuates sepsis-induced liver dysfunction in rats; the role of oxidative stress, apoptosis, and JNK1/2-P38 signaling pathways.

  2023cites this paper
• The emerging roles and therapeutic potential of B cells in sepsis

  2022cites this paper
• High Mobility Group Proteins in Sepsis

  2022cites this paper
• Anti-Septic Potential of 7-α-Obacunyl Acetate Isolated from the Toona sinensis on Cecal Ligation/Puncture Mice via Suppression of JAK-STAT/NF-κB Signal Pathway

  2021cites this paper
• Modulation of HMGB1 Release for Treating Lethal Infection and Injury

  2019cites this paper
• Severe Trauma and Sepsis

  2019cites this paper
• Evaluation of the Effect of Intravenous Immunoglobulin Dosing on Mortality in Patients with Sepsis: A Network Meta-analysis.

  2019cites this paper
• Intravenous immunoglobulin attenuates cecum ligation and puncture -induced acute lung injury by inhibiting apoptosis of alveolar epithelial cells.

  2019cites this paper
• Impaired B-Cell Maturation Contributes to Reduced B Cell Numbers and Poor Prognosis in Sepsis.

  2019cites this paper
• Serum albumin nanoparticles vaccine provides protection against a lethal Pseudomonas aeruginosa challenge.

  2018cites this paper
• Mechanistic Modelling of Drug-Induced Liver Injury: Investigating the Role of Innate Immune Responses

  2017cites this paper
• Therapeutic potential of recombinant thrombomodulin for lung injury after pneumonectomy via inhibition of high-mobility group box 1 in mice

  2016cites this paper
• Ketamine attenuates sepsis-induced acute lung injury via regulation of HMGB1-RAGE pathways.

  2016cites this paper
• Efficacy of intravenous immunoglobulin treatment in immunocompromised children with H1N1 influenza: a clinical observation

  2016cites this paper
• Is vitamin d deficiency a mechanistic driver of acute lung injury

  2015cites this paper
• Intravenous immunoglobulin use in septic shock patients after emergency laparotomy.

  2015cites this paper
• Metabolism-mediated drug interaction potential of HS-23, a new herbal drug for the treatment of sepsis in human hepatocytes and liver microsomes

  2015influential citation
• The efficacy of spironolactone and surfactant treatment on HMGB 1 , CRP , IL-1 b and TNF-a levels in acute lung injury

  2015cites this paper
• Targeting HMGB1 in the treatment of sepsis

  2014cites this paper
• HMGB1 in health and disease.

  2014cites this paper
• Intravenous Immunoglobulin-Induced Neutrophil Apoptosis in the Lung during Murine Endotoxemia

  2014cites this paper
• Effects of high-dose intravenous immunoglobulin on lipopolysaccharide-induced acute lung injury.

  2014cites this paper
• Uncoupling of Peripheral and Master Clock Gene Rhythms by Reversed Feeding Leads to an Exacerbated Inflammatory Response After Polymicrobial Sepsis in Mice

  2014cites this paper
• Molecular mechanism and therapeutic modulation of high mobility group box 1 release and action: an updated review

  2014cites this paper
• Alternate day calorie restriction improves systemic inflammation in a mouse model of sepsis induced by cecal ligation and puncture.

  2012cites this paper
• Intravenous immunoglobulin preparation attenuates LPS-induced production of pro-inflammatory cytokines in human monocytic cells by modulating TLR4-mediated signaling pathways

  2012cites this paper
• Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspective

  2012cites this paper
• Intravenous Immunoglobulin Prevents Murine Antibody-Mediated Acute Lung Injury at the Level of Neutrophil Reactive Oxygen Species (ROS) Production

  2012cites this paper
• Presence of Preexisting Antibodies MEDIATES SURVIVAL in Sepsis

  2012cites this paper
• Role of high mobility group box 1 in inflammatory disease: Focus on sepsis

  2012cites this paper
• Role of high mobility group box 1 in inflammatory disease: Focus on sepsis

  2012cites this paper
• A case of acute respiratory distress syndrome associated with novel H1N1 treated with intravenous immunoglobulin G.

  2011cites this paper
• Extracellular Administration of BCL2 Protein Reduces Apoptosis and Improves Survival in a Murine Model of Sepsis

  2011cites this paper
• HMGB1 is a therapeutic target for sterile inflammation and infection.

  2011cites this paper
• High mobility group box 1 protein as a potential drug target for infection- and injury-elicited inflammation.

  2010cites this paper
• Role of Apoptosis in Amplifying Inflammatory Responses in Lung Diseases

  2010cites this paper
• Year in review in Intensive Care Medicine 2009: II. Neurology, cardiovascular, experimental, pharmacology and sedation, communication and teaching

  2010cites this paper
• Role of Apoptosis in Amplifying Inflammatory Responses in Lung Diseases

  2010cites this paper
• High-mobility-group box chromosomal protein 1 as a new target for modulating stress response

  2010cites this paper
• Immunoglobulin, Sepsis, and Pneumonia

  2009cites this paper
• Year in review in Intensive Care Medicine, 2008: II. Experimental, acute respiratory failure and ARDS, mechanical ventilation and endotracheal intubation

  2009cites this paper
• NOVEL HMGB1-INHIBITING THERAPEUTIC AGENTS FOR EXPERIMENTAL SEPSIS

  2009cites this paper
• Therapeutic potential of HMGB1-targeting agents in sepsis

  2008cites this paper